GLUCOPHAGE vs GLUMETZA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Attribute	GLUCOPHAGE	GLUMETZA
Rating	70/100	New
Pharmacy pays	~$0.74 /30	~$0.74 /30
Type	RX	RX
Active ingredient	METFORMIN HYDROCHLORIDE	METFORMIN HYDROCHLORIDE
Manufacturer	Emd Serono	Santarus
Dosage forms	Tablet	Tablet, extended release
Drug class	Biguanide	Biguanide
Boxed warning	None	Boxed warning
Half-life	about 6.2 hours (plasma elimination half-life in adults with normal kidney function)	about 6.2 hours (plasma elimination half-life in adults with normal kidney function)
Treats	Type 2 Diabetes Mellitus	Type 2 Diabetes Mellitus

glucophage glumetza

Rating

70/100

New

Pharmacy pays

~$0.74 /30

Type

Active ingredient

METFORMIN HYDROCHLORIDE

Manufacturer

Emd Serono

Santarus

Dosage forms

Tablet

Tablet, extended release

Drug class

Biguanide

Boxed warning

None

Boxed warning

Half-life

about 6.2 hours (plasma elimination half-life in adults with normal kidney function)

Treats

Type 2 Diabetes Mellitus

Get glucophagehigher-rated option

Advertising disclosure: Some links are affiliate links. We may earn a commission at no extra cost to you. This never affects our independent ratings.

Get treatment online

Licensed online providers — consult & get prescribed if eligible.

SesameCompare online visit prices

Frequently asked questions

Which is cheaper, Glucophage or Glumetza?

Pharmacies pay about the same to acquire either one — roughly $0.74 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.

What is the difference between Glucophage and Glumetza?

Both Glucophage and Glumetza share the active ingredient Metformin Hydrochloride.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.